E
M
Emily Mullin
I am MIT Technology Review’s associate editor for biomedicine. I report from Washington, D.C., where I look for stories about how new technology is making us healthier and our medicine better. I am particularly interested in how these advances are affecting real people. Previously, I was a contributor at Forbes, and before that, an associate editor at FierceBiotech. Get in touch at emily.mullin@technologyreview.com.
emilylmullin-
May 31, 2018
Gene therapy is saving children’s lives—but screening to discover who needs it is lagging behind -
May 30, 2018
FDA halts one of the first human CRISPR studies before it begins -
May 29, 2018
A stem-cell transplant in the womb appears to have saved a baby girl’s life -
May 16, 2018
Congo aims to stop its Ebola outbreak with an experimental vaccine -
May 14, 2018
Here comes a more precise version of CRISPR -
May 4, 2018
Before he died, this biohacker was planning a CRISPR trial in Mexico -
May 1, 2018
This year, the US government plans to start collecting genetic data from 1 million people -
April 30, 2018
Billions of dollars are at stake, so the fight over who owns CRISPR is back in court -
April 26, 2018
These DNA testing companies are mainly trying to sell you other stuff -
April 23, 2018
A worldwide conservation effort aims to sequence the genomes of 1.5 million organisms - See all of Emily Mullin's stories